Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chromium picolinate is a coordination complex consisting of trivalent chromium (chromium(III)) and three molecules of picolinic acid, with the chemical formula C18H12CrN3O6. It appears as a reddish-pink or dark violet crystalline powder, is poorly soluble in water, and is chemically stable at room temperature. Used primarily as a dietary supplement, it aims to optimize insulin function in patients with type 2 diabetes and promote weight loss. The compound enhances insulin sensitivity by promoting glucose utilization and increasing the sensitivity of the insulin receptor. It may also help regulate blood pressure, blood sugar levels, cholesterol levels, and support lean muscle mass development[1][4][5]. While some studies suggest benefits for glycemic control in type 2 diabetes or lipid profile improvement, evidence for significant effects on weight loss or athletic performance remains limited[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chromium picolinate.